StonvexLoading…
StonvexStonvexStonvexCore line items from CNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.08B | $4.16B | $3.12B | $2.12B |
Operating Income | $32.71M | $-182.06M | $-84.97M | $-73.16M |
Net Income | $21.04M | $-153.22M | $-74.23M | $-36.56M |
EPS (Diluted) | $0.41 | $-2.98 | $-1.44 | $-2.06 |
Total Assets | $6.06B | $6.13B | $6.20B | $6.21B |
Total Liabilities | $2.40B | $2.45B | $2.42B | $2.44B |
Cash & Equivalents | $412.71M | $432.17M | $444.67M | $413.18M |
Free Cash Flow OCF − CapEx | $46.30M | $21.17M | $-4.86M | $-43.48M |
Shares Outstanding | 50.57M | 50.98M | 51.22M | 51.48M |